05:09 PM EDT, 05/13/2025 (MT Newswires) -- Azenta ( AZTA ) said Tuesday Azenta Life Sciences's Genewiz and Form Bio is partnering on developing adeno-associated virus gene therapy via an integrated sequencing and data analysis solution.
The partnership will combine Genewiz's sequencing services for AAV gene therapy with Form Bio's AI-backed analysis pipelines, Azenta ( AZTA ) said.